Personalis Ownership
| PSNL Stock | USD 6.40 0.21 3.39% |
Shares in Circulation | First Issued 2018-03-31 | Previous Quarter 72.9 M | Current Value 87.5 M | Avarage Shares Outstanding 42 M | Quarterly Volatility 15 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Personalis | Build AI portfolio with Personalis Stock |
Personalis Stock Ownership Analysis
About 31.0% of the company outstanding shares are owned by corporate insiders. The book value of Personalis was at this time reported as 2.35. The company has Price/Earnings To Growth (PEG) ratio of 0.09. Personalis recorded a loss per share of 1.29. The entity had not issued any dividends in recent years. Personalis, Inc. operates as a cancer genomics company worldwide. Personalis, Inc. was incorporated in 2011 and is headquartered in Menlo Park, California. Personalis operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 325 people. To find out more about Personalis contact Christopher Hall at 650 752 1300 or learn more at https://www.personalis.com.Personalis Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Personalis is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Personalis backward and forwards among themselves. Personalis' institutional investor refers to the entity that pools money to purchase Personalis' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Marshall Wace Asset Management Ltd | 2025-03-31 | 696.3 K | Nikko Asset Management Americas Inc | 2025-03-31 | 676 K | Sumitomo Mitsui Trust Group Inc | 2025-03-31 | 676 K | Dimensional Fund Advisors, Inc. | 2025-03-31 | 635 K | Kennedy Capital Management Inc | 2025-03-31 | 604.3 K | Morgan Stanley - Brokerage Accounts | 2025-03-31 | 560 K | Geode Capital Management, Llc | 2025-03-31 | 514.2 K | State Treasurer State Of Michigan | 2025-03-31 | 493.8 K | Wellington Shields Capital Mgmt Llc | 2025-03-31 | 426.3 K | Merck & Co Inc | 2025-03-31 | 14 M | Lightspeed Management Co Llc | 2025-03-31 | 8.2 M |
Personalis Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Personalis insiders, such as employees or executives, is commonly permitted as long as it does not rely on Personalis' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Personalis insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Personalis' latest congressional trading
Congressional trading in companies like Personalis, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Personalis by those in governmental positions are based on the same information available to the general public.
| 2020-06-04 | Representative Brian Mast | Acquired $15K to $50K | Verify | ||
| 2020-05-04 | Representative Brian Mast | Acquired Under $15K | Verify |
Personalis Outstanding Bonds
Personalis issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Personalis uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Personalis bonds can be classified according to their maturity, which is the date when Personalis has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Personalis Corporate Filings
8K | 9th of July 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 20th of May 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 14th of May 2025 Other Reports | ViewVerify | |
| 3rd of April 2025 Other Reports | ViewVerify |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Personalis. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more information on how to buy Personalis Stock please use our How to buy in Personalis Stock guide.You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Personalis. If investors know Personalis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Personalis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.29) | Revenue Per Share | Quarterly Revenue Growth 0.055 | Return On Assets | Return On Equity |
The market value of Personalis is measured differently than its book value, which is the value of Personalis that is recorded on the company's balance sheet. Investors also form their own opinion of Personalis' value that differs from its market value or its book value, called intrinsic value, which is Personalis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Personalis' market value can be influenced by many factors that don't directly affect Personalis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Personalis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Personalis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Personalis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.